Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

277 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.
Kunz R, Friedrich C, Wolbers M, Mann JF. Kunz R, et al. Among authors: mann jf. Ann Intern Med. 2008 Jan 1;148(1):30-48. doi: 10.7326/0003-4819-148-1-200801010-00190. Epub 2007 Nov 5. Ann Intern Med. 2008. PMID: 17984482
RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection.
Werner C, Baumhäkel M, Teo KK, Schmieder R, Mann J, Unger T, Yusuf S, Böhm M. Werner C, et al. Clin Res Cardiol. 2008 Jul;97(7):418-31. doi: 10.1007/s00392-008-0668-3. Epub 2008 May 3. Clin Res Cardiol. 2008. PMID: 18454336 Review.
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.
Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Mann JF, et al. Ann Intern Med. 2001 Apr 17;134(8):629-36. doi: 10.7326/0003-4819-134-8-200104170-00007. Ann Intern Med. 2001. PMID: 11304102 Clinical Trial.
Mortality in dialysis patients with cinacalcet use: A large observational registry study.
Friedl C, Reibnegger G, Kramar R, Zitt E, Pilz S, Mann JFE, Rosenkranz AR. Friedl C, et al. Eur J Intern Med. 2017 Jul;42:89-95. doi: 10.1016/j.ejim.2017.05.002. Epub 2017 May 10. Eur J Intern Med. 2017. PMID: 28499709
Effect of telmisartan on renal outcomes: a randomized trial.
Mann JF, Schmieder RE, Dyal L, McQueen MJ, Schumacher H, Pogue J, Wang X, Probstfield JL, Avezum A, Cardona-Munoz E, Dagenais GR, Diaz R, Fodor G, Maillon JM, Rydén L, Yu CM, Teo KK, Yusuf S; TRANSCEND (Telmisartan Randomised Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease) Investigators. Mann JF, et al. Ann Intern Med. 2009 Jul 7;151(1):1-10, W1-2. doi: 10.7326/0003-4819-151-1-200907070-00122. Epub 2009 May 18. Ann Intern Med. 2009. PMID: 19451556 Clinical Trial.
Changes in albuminuria predict mortality and morbidity in patients with vascular disease.
Schmieder RE, Mann JF, Schumacher H, Gao P, Mancia G, Weber MA, McQueen M, Koon T, Yusuf S; ONTARGET Investigators. Schmieder RE, et al. Among authors: mann jf. J Am Soc Nephrol. 2011 Jul;22(7):1353-64. doi: 10.1681/ASN.2010091001. Epub 2011 Jun 30. J Am Soc Nephrol. 2011. PMID: 21719791 Free PMC article.
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.
Rauen T, Eitner F, Fitzner C, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JF, Hilgers RD, Floege J; STOP-IgAN Investigators. Rauen T, et al. Among authors: mann jf. N Engl J Med. 2015 Dec 3;373(23):2225-36. doi: 10.1056/NEJMoa1415463. N Engl J Med. 2015. PMID: 26630142 Clinical Trial.
Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes.
Clase CM, Barzilay J, Gao P, Smyth A, Schmieder RE, Tobe S, Teo KK, Yusuf S, Mann JF. Clase CM, et al. Among authors: mann jf. Kidney Int. 2017 Mar;91(3):683-690. doi: 10.1016/j.kint.2016.09.038. Epub 2016 Dec 4. Kidney Int. 2017. PMID: 27927602 Clinical Trial.
Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitors.
Mann JF, Gerstein HC, Pogue J, Lonn E, Yusuf S. Mann JF, et al. Am J Cardiovasc Drugs. 2002;2(3):157-62. doi: 10.2165/00129784-200202030-00003. Am J Cardiovasc Drugs. 2002. PMID: 14727978 Review.
Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study.
Clase CM, Gao P, Tobe SW, McQueen MJ, Grosshennig A, Teo KK, Yusuf S, Mann JF; ONTARGET (ONgoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial) and TRANSCEND (Telmisartan Randomized Assessment Study in Angiotensin-Converting-Enzyme-Inhibitor Intolerant Subjects with Cardiovascular Disease). Clase CM, et al. Among authors: mann jf. Ann Intern Med. 2011 Mar 1;154(5):310-8. doi: 10.7326/0003-4819-154-5-201103010-00005. Ann Intern Med. 2011. PMID: 21357908
277 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback